Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug

Journal of Drug Targeting

Volumn 18, Issue 4, 2010, Pages 264-276

  Pitarresi, Giovanna ^a   Palumbo, Fabio Salvatore ^a   Albanese, Antonella ^a   Fiorica, Calogero ^a   Picone, Pasquale ^a,b   Giammona, Gaetano ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

Author keywords

Hyaluronic acid; Micelles; Polyethylenglycol; Polylactic acid; Selective cytotoxicity

Indexed keywords

AMPHOPHILE; COPOLYMER; DOXORUBICIN; HERMES ANTIGEN; HYALURONIC ACID; MACROGOL 200; POLYLACTIC ACID;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; DRUG TARGETING; HUMAN; HUMAN CELL; MICELLE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBOHYDRATE SEQUENCE; CELL LINE; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; HYALURONIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICELLES; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; POLYMERS;

EID: 77951135224     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903434027     Document Type: Article

References (31)

1. Bulpitt P, Aeschlimann D. (1999). New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J Biomed Mater Res, 47: 152-169. (Pubitemid 29409734)
2. Cavallaro G, Giammona G, Lombardo R, Sciascia L, Turco Liveri ML. (2006). Amphiphilic derivatives of a polyaspartamide: their aggregation and solubilization ability. Tensiometric and spectrophotometric studies. Colloids Surf A: Physicochem Eng Aspects, 289: 10-16. (Pubitemid 44472542)
3. Craparo EF, Cavallaro G, Bond?̀ML, Mandracchia D, Giammona G. (2006). Preparation, physico-chemical characterization, and intracellular uptake. Biomacromolecules, 7: 3083-3092.
4. Creuzet C, Kadi S, Rinaudo M, Auzély-Velty R. (2006). New associative systems based on alkylated hyaluronic acid. Synthesis and aqueous solution properties. Polymer, 47: 2706-2713.
5. Meo CD, Panza L, Capitani D, Mannina L, Banzato A, Rondina M, Renier D, Rosato A, Crescenzi V. (2007). Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy. Biomacromolecules, 8: 552-559. (Pubitemid 46323272)
6. Entwistle J, Hall CL, Turley EA. (1996). HA receptors: regulators of signalling to the cytoskeleton. J Cell Biochem, 61: 569-577. (Pubitemid 26240134)
7. Fraser JR, Laurent TC, Laurent UB. (1997). Hyaluronan: its nature, distribution, functions and turnover. J Intern Med, 242: 27-33.
8. Gref R, Couvreur P, Barratt G, Mysiakine E. (2003). Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials, 24: 4529-4537. (Pubitemid 36960147)
9. Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH, Turley EA. (1995). Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation. Cell, 82: 19-26.
10. Herrlich P, Sleeman J, Wainwright D, König H, Sherman L, Hilberg F, Ponta H. (1998). How tumor cells make use of CD44. Cell Adhes Commun, 6: 141-147. (Pubitemid 28519933)
11. Hu FQ, Meng P, Dai YQ, Du YZ, You J, Wei XH, Yuan H. (2008). PEGylated chitosan-based polymer micelle as an intracellular delivery carrier for anti-tumor targeting therapy. Eur J Pharm Biopharm, 70: 749-757.
12. Hua Q, Knudson CB, Knudson W. (1993). Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis. J Cell Sci, 106: 365-375. (Pubitemid 23286807)
13. Hyung W, Ko H, Park J, Lim E, Park SB, Park YJ, Yoon HG, Suh JS, Haam S, Huh YM. (2008). Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment. Biotechnol Bioeng, 99: 442-454.
14. Kim D, Lee ES, Park K, Kwon IC, Bae YH. (2008). Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/ DOXR tumor. Pharm Res, 25: 2074-2082.
15. Knudson CB, Knudson W. (1993). Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J, 7: 1233-1241.
16. Knudson CB, Knudson W. (2001). Cartilage proteoglycans. Semin Cell Dev Biol, 12: 69-78.
17. Laurent TC. (1987). Biochemistry of hyaluronan. Acta Otolaryngol Suppl, 442: 7-24.
18. Lee H, Lee K, Park TG. (2008). Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Bioconjug Chem, 19: 1319-1325.
19. Lee H, Mok H, Lee S, Oh YK, Park TG. (2007). Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release, 119: 245-252.
20. Liu SQ, Wiradharma N, Gao SJ, Tong YW, Yang YY. (2007). Biofunctional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials, 28: 1423-1433.
21. Liu SQ, Tong YW, Yang YY. (2005). Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(Nisopropylacrylamide- co-N,N-dimethylacrylamide)-b-poly(D,Llactide- co-glycolide) with varying compositions. Biomaterials, 26: 5064-5074.
22. Luo Y, Bernshaw NJ, Lu ZR, Kopecek J, Prestwich GD. (2002). Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharm Res, 19: 396-402. (Pubitemid 34408935)
23. Luo Y, Prestwich GD. (1999). Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate. Bioconjug Chem, 10: 755-763.
24. Otsuka H, Nagasaki Y, Kataoka K. (2003). PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Deliv Rev, 55: 403-419.
25. Palumbo FS, Pitarresi G, Mandracchia D, Tripodo G, Giammona G. (2006). New graft copolymers of hyaluronic acid and polylactic acid: synthesis and characterization. Carbohyd Polym, 66: 379-385.
26. Peterson RM, Yu Q, Stamenkovic I, Toole BP. (2000). Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am J Pathol, 156: 2159-2167.
27. Pitarresi G, Craparo EF, Palumbo FS, Carlisi B, Giammona G. (2007). Composite nanoparticles based on hyaluronic acid chemically crosslinked with ?,?-polyaspartylhydrazide Biomacromolecules, 8: 1890-1898.
28. Pouyani T, Prestwich GD. (1994). Functionalized derivatives of hyaluronic acid oligosaccharides: drug carriers and novel biomaterials. Bioconjug Chem, 5: 339-347.
29. Shu XZ, Liu Y, Luo Y, Roberts MC, Prestwich GD. (2002). Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules, 3: 1304-1311.
30. Turley EA. 1989. The Biology of Hyaluronan. CIBA Foundation, Ed. J. Wiley & Sons, Ltd, Chichester, UK, pp. 121.
31. Xiangyang X, Ling L, Jianping Z, Shiyue L, Jie Y, Xiaojin Y, Jinsheng R. (2007). Preparation and characterization of N-succinyl-N?-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity. Colloids Surf B Biointerfaces, 55: 222-228.